- Dopexamine
-
Dopexamine Systematic (IUPAC) name 4-[2-({6-[(2-phenylethyl)amino]hexyl}amino)ethyl]benzene-1,2-diol Clinical data AHFS/Drugs.com International Drug Names Pregnancy cat. ? Legal status ? Identifiers CAS number 86197-47-9 ATC code C01CA14 PubChem CID 55483 ChemSpider 50102 UNII 398E7Z7JB5 KEGG D03891 ChEMBL CHEMBL77622 Chemical data Formula C22H32N2O2 Mol. mass 429.43 g/mol SMILES eMolecules & PubChem (what is this?) (verify) Dopexamine is a β2-adrenergic receptor agonist. It also acts at dopamine receptors.[1]
Use in sepsis has been proposed.[2]
It is considered a inotropic agent.[3]
References
- ^ Brown RA, Dixon J, Farmer JB, et al. (July 1985). "Dopexamine: a novel agonist at peripheral dopamine receptors and beta 2-adrenoceptors". Br. J. Pharmacol. 85 (3): 599–608. PMC 1916510. PMID 2862944. http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=1916510.
- ^ Birnbaum J, Klotz E, Spies CD, et al. (2006). "Effects of dopexamine on the intestinal microvascular blood flow and leucocyte activation in a sepsis model in rats". Crit Care 10 (4): R117. doi:10.1186/cc5011. PMC 1750974. PMID 16893450. http://ccforum.com/content/10/4/R117.
- ^ Lisbon A (May 2003). "Dopexamine, dobutamine, and dopamine increase splanchnic blood flow: what is the evidence?". Chest 123 (5 Suppl): 460S–3S. doi:10.1378/chest.123.5_suppl.460S. PMID 12740229. http://www.chestjournal.org/cgi/pmidlookup?view=long&pmid=12740229.
Cardiac stimulants excluding cardiac glycosides (C01C) Adrenergic and
dopaminergic agentsαβmixedBothUnknown/ungroupedPhosphodiesterase inhibitors (PDE3I) Other cardiac stimulants #WHO-EM. ‡Withdrawn from market. Clinical trials: †Phase III. §Never to phase III This drug article relating to the cardiovascular system is a stub. You can help Wikipedia by expanding it.